Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

HIV Clinical Trials

111 recruiting trials for HIV. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
111
Total Trials
111
Recruiting Now
2
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 1 / Phase 2NCT04353778

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

The study team's prior research has shown that dysfunction of a specific nerve, called the vagus nerve, is associated with small intestinal bacterial overgrowth (SIBO), and that...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 2071 location
RECRUITINGNCT07032363

Implementing Depression and Adherence Treatment

The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to patients with HIV...

Sponsor: University of MiamiEnrolling: 103 locations
RECRUITINGPhase 4NCT07199335

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

The goal of this study is to determine the feasibility and impact of delivering long-acting injectable cabotegravir HIV pre-exposure prophylaxis and suite of support services to...

Sponsor: Massachusetts General HospitalEnrolling: 1002 locations
RECRUITINGEarly Phase 1NCT06113003

The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease

Persons with human immunodeficiency virus (HIV) have higher risk of developing fatty liver disease (NAFLD) than HIV-negative persons but the reasons for this discrepancy are not...

Sponsor: Vanderbilt University Medical CenterEnrolling: 631 location
RECRUITINGNCT07312266

Questioning the Epidemiology of Asymptomatic TB

Tuberculosis (TB) remains one of the world's leading causes of morbidity and mortality. Current TB control strategies focus largely on the binary paradigm of TB, which tackle Mtb...

Sponsor: Barcelona Institute for Global HealthEnrolling: 67701 location
RECRUITINGNCT06593080

The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis

The Decide-TB project aims to generate evidence for the implementation of a comprehensive Treatment Decision Algorithms (TDA) based approach for TB in children living in high TB...

Sponsor: Chishala ChabalaEnrolling: 3024020 locations
RECRUITINGNCT05917210

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

This cluster-randomized trial in Uganda will evaluate the effectiveness and implementation of a novel, peer-led TB education and counseling strategy to improve outcomes among...

Sponsor: Yale UniversityEnrolling: 19201 location
RECRUITINGNCT02454569

Vicente Ferrer HIV Cohort Study

The VFHCS is a long-term prospective cohort study of HIV infected patients from a resource-poor rural setting in India. The aim of the study is to use data collected from routine...

Sponsor: Rural Development Trust HospitalEnrolling: 300001 location
RECRUITINGNCT04230395

Alcohol Reduction Among People With TB and HIV in India

The highest incidence of tuberculosis disease (TB) in the world is in India, accounting for 27% of all new cases globally, with approximately 86,000 among persons with HIV (PWH)....

Sponsor: Johns Hopkins UniversityEnrolling: 4502 locations
RECRUITINGPhase 3NCT06497465

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

This will be a Phase IIIb Clinical Trial, an international multicenter, randomized, three-arm, non-comparative trial of efficacy, safety, and tolerability of the dual therapy...

Sponsor: Johns Hopkins UniversityEnrolling: 1506 locations
RECRUITINGNCT05642715

Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes

Cigarette smoking is now the leading killer of people with HIV (PWH) in the US, and most cessation strategies tried to date have failed to increase long-term quit rates. An "all...

Sponsor: Montefiore Medical CenterEnrolling: 4001 location
RECRUITINGPhase 2NCT05719441

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation...

A5388 is a phase II, two-arm, randomized, double-blind, placebo-controlled study that will enroll 48 antiretroviral therapy (ART)-naïve adults with acute HIV infection (AHI) in...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 4820 locations
RECRUITINGNCT07236905

Improving Access to HIV Testing for Children in Uganda

The goal of this study is to learn if HIV screening testing can be done for children ages 18 months to 5 years by traditional healers in Southwestern Uganda. The main questions...

Sponsor: University of California, San FranciscoEnrolling: 4001 location
RECRUITINGNCT06004011

AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)

Adolescents and young adults living with HIV experience higher premature mortality from cancer than their uninfected peers. In Zambia, because of multilevel barriers,...

Sponsor: ImplenomicsEnrolling: 41001 location
RECRUITINGNCT05689281

Increasing PrEP With Trans Women in the Deep South

The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence among trans women via a single arm stepped wedge clinical trial. The main question is...

Sponsor: CrescentCareEnrolling: 2001 location
RECRUITINGNCT06216600

Women Focused Encounters for Resilience Independence Strength and Eudaimonia

The goal of this combination Type 1 hybrid and observational study is to evaluate the impact of a peer delivered intervention of acceptance and comittment therapy(ACT) + exercise...

Sponsor: University of California, San DiegoEnrolling: 3001 location
RECRUITINGNCT07425067

Upper Gastrointestinal Endoscopy in HIV-infected Individuals

The aim of this registry is to collect prospectively demographic characteristics and upper gastrointestinal endoscopy diagnoses over a long-term period, in people living with HIV,...

Sponsor: Centre Hospitalier Universitaire Saint PierreEnrolling: 25001 location
RECRUITINGNCT07226492

Cash Transfers to Pregnant Women With HIV

The goal of this study is to evaluate the effectiveness and implementation of an unconditional cash transfer intervention to improve mental bandwidth, ART adherence, and...

Sponsor: University of PennsylvaniaEnrolling: 1003 locations
RECRUITINGNCT06770101

Suicide Assessment and Feasible Evidence-based Treatments for Youth Living With HIV in Lilongwe

The overall aim of this study is to determine the feasibility, fidelity, acceptability, and preliminary effectiveness of the Friendship Bench +Safety Planning intervention in...

Sponsor: University of PennsylvaniaEnrolling: 604 locations
RECRUITINGNCT07429864

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

HDV is an RNA virus that infects only in the presence of HBV, affecting about 13% of HBsAg carriers. In Italy, prevalence ranges from 3.2% to 9.3%. It increases the risk of...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 201 location
RECRUITINGPhase 1NCT07390955

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

This study is testing a lab-made antibody called ePGT121v1-LS that targets a specific part of HIV. Researchers will give it by vein (IV) and under the skin (SC), both on its own...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 8310 locations
RECRUITINGNCT05413798

Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa

The purpose of this study explores the usefulness of urine samples for cervical cancer screening in human immunodeficiency virus (HIV)-infected women. Cervical cancer occurs when...

Sponsor: UNC Lineberger Comprehensive Cancer CenterEnrolling: 3001 location
RECRUITINGNCT05404958

Systems Analysis and Improvement Approach to Improve Integration of HIV Prevention and Treatment Services

East and Southern Africa is home to 6.2% of the world's population but includes 54% of all people living with HIV (PLWH). In this region, three out of five PLWH are women, and...

Sponsor: University of WashingtonEnrolling: 401 location
RECRUITINGNCT05881447

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity and mortality. The prevalence of CKD is increasing worldwide and is assumed to also dramatically...

Sponsor: Swiss Tropical & Public Health InstituteEnrolling: 12001 location
RECRUITINGPhase 2NCT07030920

Reducing Systemic Inflammation in People on Antiretroviral Therapy

This randomized, open-label clinical trial will evaluate whether adding fostemsavir to current antiretroviral therapy can reduce the risk of cardiovascular disease in people with...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1501 location
RECRUITINGPhase 1 / Phase 2NCT04303117

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Background: Kaposi sarcoma (KS) tumors grow on the skin, lymph nodes, lungs, bone, and gastrointestinal tract. KS often affects people with immune deficiencies, such as among...

Sponsor: National Cancer Institute (NCI)Enrolling: 801 location
RECRUITINGPhase 2NCT05443555

Gabapentin to Reduce Alcohol and Improve Viral Load Suppression

GRAIL is a Randomized Controlled Trial (RCT) among 300 HIV-positive persons with heavy alcohol consumption (by NIAAA definition) who have had detectable HIV viral load (HVL) at...

Sponsor: Boston Medical CenterEnrolling: 2201 location
RECRUITINGNCT06367348

An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi

With a full-scale randomized control trial, the investigators will evaluate the efficacy and cost effectiveness of Mlambe, an economic and relationship-strengthening intervention...

Sponsor: University of California, San FranciscoEnrolling: 5001 location
RECRUITINGPhase 1 / Phase 2NCT05586581

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

The purpose of this study is to longitudinally characterize and evaluate changes in synaptic density in the brain using novel positron-emission tomography (PET) scans; magnetic...

Sponsor: Yale UniversityEnrolling: 701 location
RECRUITINGPhase 2 / Phase 3NCT04147286

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

This is a proof-of-concept phase IIB, double-blind, randomized, placebo-controlled trial to evaluate the safety and efficacy of 40 mg atorvastatin to reduce persistent lung...

Sponsor: University of Cape TownEnrolling: 2201 location
RECRUITINGNCT05789901

The MARVIN Chatbots to Provide Information for Different Health Conditions

This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast...

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 4002 locations
RECRUITINGNCT05129345

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals. Aim 2:...

Sponsor: Duke UniversityEnrolling: 1502 locations
RECRUITINGPhase 1NCT07392372

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and...

This study will test the safety and blood levels of the antibody BNT351 in people living without and with human immunodeficiency virus (HIV). This study will also test the...

Sponsor: BioNTech SEEnrolling: 613 locations
RECRUITINGNCT05090267

The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol,...

This project uses a hybrid trial design to evaluate two biomedical interventions targeting the gut-brain axis. One intervention is portable Transcutaneous Vagus Nerve Stimulator,...

Sponsor: University of FloridaEnrolling: 801 location
RECRUITINGPhase 1NCT05487807

Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia

This proposal tests the efficacy of a phone-based tobacco cessation intervention for people living with HIV (PLWH) in comparison to the standard of care (brief advice to quit) and...

Sponsor: University of Southern CaliforniaEnrolling: 8002 locations
RECRUITINGNCT06405464

Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for...

This study aims to characterize Swiss HIV Cohort Study participants initiating the CAB+RPV LA regimen, assess adherence to Swiss label indications, and describe treatment outcomes...

Sponsor: University of ZurichEnrolling: 6001 location
RECRUITINGNCT05330923

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

Identifying patients at risk of NAFLD(Nonalcoholic fatty liver disease), especially severe disease with NASH(nonalcoholic steatohepatitis) and fibrosis, is critical. Prevalence of...

Sponsor: Peking Union Medical College HospitalEnrolling: 2001 location
RECRUITINGNCT06286527

Quality of Sexual Life of PrEP Users

The study will recruit participants on the occasion of their visit in a sexual health center or another HIV pre-exposure prophylaxis (PrEP) facility in France. PrEP users will be...

Sponsor: University Hospital, GrenobleEnrolling: 10001 location
RECRUITINGPhase 2NCT04521803

High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis

The investigators hypothesise that high dose RIF (RIF35) will increase pericardial fluid RIF exposure and so enhance mycobacterial clearance, compared to standard of care dosing...

Sponsor: University of Cape TownEnrolling: 602 locations
RECRUITINGPhase 4NCT06474364

HIV Prevention and Care Interventions for Youth in Uganda

Several studies show that Adolescents and Young Adults (AYA) have poor outcomes along the entire Human Immunodeficiency Virus (HIV) prevention and care cascades compared to...

Sponsor: MU-JHU CAREEnrolling: 6001 location
RECRUITINGNCT06894199

Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority Men

The goal of this observational study is to learn about the pilot test of the employment program among young Black sexual minority men. The main question it aims to answer is:...

Sponsor: University of ChicagoEnrolling: 1321 location
RECRUITINGPhase 1NCT03240328

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

To study the safety and effectiveness of CAR-T Cell therapy on HIV patients whose plasma HIV has been successfully suppressed after cART, which is expected to enhance the...

Sponsor: Guangzhou 8th People's HospitalEnrolling: 401 location
RECRUITINGNCT06637436

PrEP Readiness Interventions for Sustained Motivation (PRISM)

This is a hybrid type I, factorial randomized controlled trial to test the comparative and combined effectiveness of contingency management (CM) alone or CM with motivational...

Sponsor: Florida International UniversityEnrolling: 4002 locations
RECRUITINGNCT07512869

Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A...

This study evaluates the pre-implementation phase of a host-led harm reduction model for men who have sex with men (MSM) engaging in chemsex in Bangkok, Thailand, focusing on...

Sponsor: Institute of HIV Research and Innovation Foundation, ThailandEnrolling: 761 location
RECRUITINGNCT06062342

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g.,...

Sponsor: University of MiamiEnrolling: 204001 location
RECRUITINGNCT07225894

PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pilot Phase

The investigators will pilot test an ethnodrama intervention designed to transform community member beliefs about and foster support of young cisgender women (YCW) using...

Sponsor: Duke UniversityEnrolling: 1601 location
RECRUITINGNCT06889805

HDV Screening Study

This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.

Sponsor: Grace Lai Hung WongEnrolling: 3001 location
RECRUITINGNCT06656676

WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women

HIV prevalence among transgender women (TW) in the United States is high (\~14%). The best way to reduce HIV incidence in this population is to link TW to HIV pre-exposure...

Sponsor: University of Colorado, DenverEnrolling: 751 location
RECRUITINGNCT06263426

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.

Sponsor: Johns Hopkins UniversityEnrolling: 20013 locations
RECRUITINGNCT06072443

AURORA Study-A Transformative Approach to Support PrEP Medication Persistence

This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion...

Sponsor: WV Health Right, Inc.Enrolling: 1051 location

Showing 50 of 111 trials.Search all HIV trials

Frequently Asked Questions

There are currently 111 clinical trials for HIV, with 111 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for HIV, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 2 Phase 3 trials for HIV, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.